Guangzhou, China

Yizhi Liu

USPTO Granted Patents = 5 

 

 

Average Co-Inventor Count = 5.8

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Guangzhou, CN (2015 - 2020)
  • Guangdong, CN (2021)

Company Filing History:


Years Active: 2015-2025

where 'Filed Patents' based on already Granted Patents

5 patents (USPTO):

Title: Yizhi Liu: A Pioneer in Ophthalmic Drug Innovations

Introduction: Yizhi Liu is an accomplished inventor based in Guangzhou, China, known for his significant contributions to the field of ophthalmic biotechnology. With a robust portfolio of four patents, Liu's work focuses on the development of novel compounds aimed at treating various ophthalmic diseases. His research underscores the importance of innovative approaches in addressing critical health challenges in the field of eye care.

Latest Patents: Liu's most recent patents demonstrate his expertise and dedication to advancing ophthalmic treatments. One of his key inventions is the "Composition of lanosterol prodrug compound, preparation method therefor and use thereof." This patent details a composition that includes a compound designed for drug preparation to treat ophthalmic diseases. Another noteworthy patent is the "Crystal form of lanosterol prodrug compound and application thereof," which relates to a specific crystal form of the compound and its application in developing drugs for ophthalmic conditions. These innovations provide promising avenues for improved therapeutic options in eye care.

Career Highlights: Throughout his career, Yizhi Liu has worked with leading organizations in the field of ophthalmic biotechnology. He has been associated with Guangzhou Ocusun Ophthalmic Biotechnology Co., Ltd. and the Zhongshan Ophthalmic Center at Sun Yat-sen University. His roles in these institutions have allowed him to harness his research capabilities and bring innovative solutions to the market.

Collaborations: Collaboration has been a pivotal aspect of Liu's work. He has notably worked with distinguished colleagues such as Zhi Luo and Haiying He. These collaborative efforts underscore the power of teamwork in driving forward significant advancements in the biotechnology sector.

Conclusion: Yizhi Liu's contributions to the field of ophthalmic drug innovation highlight the potential of inventive minds in tackling pressing health issues. His patents not only reflect his dedication to research and development but also signify critical advancements in treating ophthalmic diseases. As the industry continues to evolve, Liu's work will undoubtedly inspire further innovations in biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…